WHC is still in active development. Read this to understand our approach.
depiction of MVWVFYHBGMAFLY-UHFFFAOYSA-N.svg
isomerdesign

Ziprasidone

Check on isomerdesign

pubchem

Ziprasidone

Check on pubchem

drugmap

Ziprasidone

Check on drugmap

wiki

Ziprasidone

Check on wiki

Data

InChI: InChI=1S/C21H21ClN4OS/c22-17-13-18-15(12-20(27)23-18)11-14(17)5-6-25-7-9-26(10-8-25)21-16-3-1-2-4-19(16)28-24-21/h1-4,11,13H,5-10,12H2,(H,23,27)

Synonyms: NCGC00263539-03,Ziprasidone solution, 1.0 mg/mL in 1,2-dimethoxyethane, ampule of 1 mL, certified reference material,BIDD:GT0042,BDBM50048803,DB00246, Ziprazidone,Ziprasidone [INN:BAN],5-{2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-2,3-dihydro-1H-indol-2-one,Geodon, TC-5280, DSSTox_RID_77186,SCHEMBL28028, CHEBI:10119,ZIPRASIDONE [MI],UNII-6UKA5VEJ6X,Ziprasidone-[d8],AC-23360,6UKA5VEJ6X, C21H21ClN4OS, CP-88,059-1,CS-1071, ziprasidona,VU0286234-2,Ziprasidone,DSSTox_GSID_23753,HMS3742M19,MLS000759435,CP-88059,5-[2-(4-Benzo[d]isothiazol-3-yl-piperazin-1-yl)-ethyl]-6-chloro-1,3-dihydro-indol-2-one(Norastemizole),Zipradon (TN), Ziprasidone [INN:BAN],CAS-146939-27-7, Zipradon (TN), 5-(2-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6-chloroindolin-2-one, Geodon,DSSTox_RID_77186,CP-88059-27,DSSTox_CID_3753,Z0034,CP 88059;CP-88059;CP88059,GTPL59,Ziprasidone- Bio-X,2H-Indol-2-one, 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-,L000659, 5-{2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-1,3-dihydro-2H-indol-2-one, Ziprasidona,HY-14542,ziprasidonum,AB00639925-04, CP-88,059-01, 5-{2-[4-(1,2-benzisothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-1,3-dihydro-2H-indol-2-one,2H-Indol-2-one, 5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-,A807468,SDCCGSBI-0633778.P001,AB00639925_05, DSSTox_GSID_23753,ZIPRASIDONE [WHO-DD],A808568, ziprazidone,AKOS015900383,5-(2-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6-chloroindolin-2-one, ziprasidonum, Zeldox (TN),NCGC00186050-01,D08687, CP 88059,Zipradon,5-{2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-1,3-dihydro-2H-indol-2-one,AB00639925-02,BZ164575, UNII-6UKA5VEJ6X,ZIPRASIDONE [HSDB],Tox21_112194,Q205517,5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2H-indol-2-one,NCGC00263539-05,5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2H-indole-2-one, Geodon,NCGC00263539-13, CP-88,059, 5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-1,3-dihydroindol-2-one, Ziprasidone hydrochloride,BVB74558,Ziprasidone (INN),5-[2-(4-Benzo[d]isothiazol-3-yl-piperazin-1-yl)-ethyl]-6-chloro-1,3-dihydro-indol-2-one (Ziprasidone),146939-27-7,ZIPRASIDONE [VANDF], 6-chloro-5-[2-[4-(7-thia-8-azabicyclo[430]nona-1,3,5,8-tetraen-9-yl)piperazin-1-yl]ethyl]-1,3-dihydroindol-2-one,Zeldox,EN300-7415908,5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2h-indol-2-one,5-[2-[4-(1,2-Benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2H-indol-2-one hydrochloride monohydrate,HSDB 7745,ziprasidona,5-{2-[4-(1,2-benzisothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-1,3-dihydro-2H-indol-2-one,Tox21_112194_1,NCGC00263539-01,DTXSID4023753,ZIPRASIDONE [MART.], CHEMBL708, 6UKA5VEJ6X,C07568, CP 88059-01,CP 88059,AB00639925_06,ZIPRASIDONE [INN], DSSTox_CID_3753,FT-0655916,ZINC538550, Ziprasidone mesylate trihydrate, Ziprasidonum, CP-88059-1,D92803,CHEMBL708, Ziprasidone (INN),AM90310,5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one,883Z936,FT-0654208,SMR000466328, Zeldox,5-[2-(4-Benzo[d]isothiazol-3-yl-piperazin-1-yl)-ethyl]-6-chloro-1,3-dihydro-indol-2-one, Geodon (TN),5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-1,3-dihydroindol-2-one,Tox21_113525,CP88059;5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-indolin-2-one, Zipradon,CHEBI:10119

Estimated data

Solubility: -5.061 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 34.7% (prediction based on www.mdpi.com)

Similarities

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.